Remove Definition Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

Sanofi to sell Japanese manufacturing plant

European Pharmaceutical Review

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Packaging 104
article thumbnail

2022 ISPE Annual Meeting: Transform, Collaborate, & Innovate for the Path Forward

ISPE

Applying what has been learned over the last three years to update pharmaceutical companies’ approaches to development and implementation is key as the industry crafts its strategies in an increasingly digital and global environment. Pfizer “cleared runway to allow for large-scale vaccine manufacturing before we had a product!”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare’s COVID-19 backlog: how pharma can help

pharmaphorum

Even past the second wave, as vaccines become available, healthcare systems will not return rapidly to pre-pandemic capacities, let alone deliver more than that capacity. Pharmaceutical companies cannot address this challenge alone. The conclusion is that backlog clearance will extend into 2021.

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

Innovation across the healthcare system is needed to realise the value of medicines

pharmaphorum

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. The answer to this question comes back to our definition of value. And it all fuels the debate: are medicines a cost or an investment? About the author.

article thumbnail

Deep Dive: Digital Health 2022

pharmaphorum

From the unknowns of blurry radiation to a world of high-definition visuals, medical imaging has pulled back the curtain on the inner workings of the human body. Influencer culture has well and truly taken over the internet, with numerous benefits on offer for pharmaceutical companies in the healthcare influencer space.

article thumbnail

Nine for 2021: The COVID-19 legacy

pharmaphorum

One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible. Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at.

Hospitals 105